head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2019, vol. 25, issue1
Subject Area: Medicine
DOI: 10.5272/jimab.2019251.2369
Published online: 18 February 2019

Original article

J of IMAB. 2019 Jan-Mar;25(1):2369-2372
Tsvetelina Kostadinova1ORCID logo Corresponding Autoremail, Liliya Ivanova2,3, Denitsa Tsaneva2ORCID logo, Neli Ermenlieva4ORCID logo, Zhivka Stoykova2,3ORCID logo, Gabriela Tsankova4ORCID logo,
1) Section Medical Lab Technicians, Medical College, Medical University, Varna, Bulgaria.
2) Department of Microbiology and Virology-Medical University Varna, Bulgaria
3) Laboratory of Clinical Virology-University hospital St. Marina, Varna, Bulgaria
4) Department of Preclinical and Clinical Sciences, Faculty of Pharmacy, Medical University, Varna, Bulgaria.

Purpose: The Epstein-Barr virus (EBV) is widespread in the human population and is the major cause of infectious mononucleosis. Also, the virus is associated with the development of Hodgkin's and non-Hodgkin's lymphomas and nasopharyngeal carcinoma. The evidence of its role in neonatal pathology is contradictory and not well known. The aim of this study is to evaluate the EBV serostatus of women of reproductive age in the Varna region (2010-2016) to determine the risk of intrauterine and early postnatal EBV infection.
Materials/Methods: We analyzed the results of a total of 1126 women of reproductive age and 360 children up to 1 year tested for anti-VCA IgM (viral capsid antigen) and anti-VCA IgG. An indirect ELISA of Euroimmun – Germany was used.
Results: The proportion of positive anti-VCA IgG women in the reproductive age (76.8%; 95% CI: 74.2 %-79.3%) correlates with that of children up to 6 months - 68.0% (95% CI: 62.1% -73.6%), Pearson's = 8.395, p = 0.004.
Conclusion: We found high anti-VCA IgG seropositivity among women of reproductive age, which reduces the risk of infection during pregnancy and intrauterine infection of the fetus, respectively. The presence of seronegative women (around 6.0%) and of women with serological evidence of primary infection or reactivation (17%) assumes a group of babies at risk of early infection. Despite the little evidence of virus involvement in neonatal pathology, contamination should be considered and sought after excluding the most common infectious agents.

Keywords: Epstein-Barr virus, reproductive age, anti-VCA IgМ, anti-VCA IgG, newborns,

pdf - Download FULL TEXT /PDF 558 KB/
Please cite this article as: Kostadinova Ts, Ivanova L, Tsaneva D, Ermenlieva N, Stoykova Zh, Tsankova G. Distribution of Epstein - Barr virus among women of reproductive age and children up to 1 year in the Varna region. J of IMAB. 2019 Jan-Mar;25(1):2369-2372. DOI: 10.5272/jimab.2019251.2369

Corresponding AutorCorrespondence to: Tsvetelina Kostadinova Popova, Section Medical Lab Technicians, Medical College, Medical University, Varna; 84 Tsar Osvoboditel Blvd., Varna, Bulgaria; E-mail: ckostadinova@abv.bg

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000 Aug;343(7):481-92. [PubMed] [Crossref]
2. Kostadinova Ts, Ivanova L, Raykov T, Stojkova Z, Tsankova G. Seroprevalence of Epstein-Barr Virus in North-Eastern Bulgaria. Acta Microbiol Bulg. 2016 Sep;32(3):33-38.
3. Eskild  A, Bruu A, Stray-Pedersen B, Jenum P. Epstein–Barr virus infection during pregnancy and the risk of adverse pregnancy outcome.BJOG. 2005 Dec;112(12):1620-4. [PubMed]
 4. Zhu P, Chen YJ, Hao JH,  Ge JF, Huang K, Tao RX, et al. Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy. Sci  Rep. 2013 Oct;3:3096. [PubMed]
5. Avgil M, Ornoy A. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol. 2006 May;21(4):436-45. [PubMed]
6. Tomai XH. Stillbirth following severe symmetric fetal growth restriction due to reactivation of Epstein-Barr virus infection in pregnancy. J Obstet Gynaecol Res. 2011 Dec;37(12):1877-82. [PubMed] [Crossref]
7. Chan KH, NG MH, Seto WH, Peiris JSM.  Epstein-Barr Virus (EBV) DNA in Sera of Patients with Primary EBV Infection. J.Clin. Microbiol. 2001 Nov;39(11):4152–4.  
8. Dundarov S, Ivanova L. Human herpes viruses implicated in neonatal herpes. Infectologia.1998; 3:3-6.
9. Crawford DH, Swerdlow AJ, Higgins C, McAulay K, Harrison N, Williams H, et al. Sexual history and Epstein-Barr virus infection. J Infect Dis. 2002 Sep 15;186(6):731-6. [PubMed]
10. Ivanova, L. Herpesvirus infections in human population in North/Eastern Bulgaria. Scripta Sci. Med. 2007; 39(2):125-128.
11. Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, et al. Seroprevalence of Cytomegalovirus, Epstein Barr Virus and Varicella Zoster Virus among Pregnant Women in Bradford: A Cohort Study. PLoS One. 2013 Nov 27;8(11):e81881. [PubMed] [Crossref]
12. Suntornlohanakul R, Wanlapakorn N, Vongpunsawad S, Thongmee T, Chansaenroj J, Poovorawan Y. Seroprevalence of Anti-EBV IgG among Various Age Groups from Khon Kaen Province, Thailand. Asian Pac J Cancer Prev. 2015;16(17):7583-7. [PubMed]
13. Haeri S, Baker AM, Boggess KA. Prevalence of Epstein-Barr virus reactivation in pregnancy. Am J Perinatol. 2010 Oct;27(9):715-9. [PubMed]
14. Lehtinen M, Koskela P, Ogmundsdottir HM, Bloigu A, Dillner J, Gudnadottir M, et al. Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. Am J Epidemiol., 2003 Aug 1;158(3):207-13. [PubMed].

Received: 09 June 2018
Published online: 18 February 2019

back to Online Journal